Showing 119 of 119on this page. Filters & sort apply to loaded results; URL updates for sharing.119 of 119 on this page
A Compound L1196M/G1202R ALK Mutation in a Patient with ALK-Positive ...
(PDF) Overcoming resistance by ALK compound mutation (I1171S + G1269A ...
Overcoming resistance by ALK compound mutation (I1171S + G1269A) after ...
Development of compound ALK mutations corresponds with tumor resistance ...
Spectrum of compound ALK mutations identified in lorlatinib-resistant ...
Drug screening of Ba/F3 ALK mutation models identifies LAs with ...
Structural basis for selectivity of LA7 and LA9 against ALK compound ...
Cellular IC50 changes with single and compound ALK mutations a,b ...
Sensitivity of compound 001-017 against drug-resistant mutants of ALK ...
Treatment with Next-Generation ALK Inhibitors Fuels Plasma ALK Mutation ...
Cellular and biochemical studies of ALK compound mutations a Cell ...
Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ...
The ALK mutation L1152R causes the ALK tyrosine kinase inhibitor ...
(PDF) A compound heterozygous mutation of the alkaline phosphatase ALPL ...
ALK Tyrosine Kinase Focused Library - Compound Library Design / BOC ...
Concomitant ALK translocation and EGFR mutation in lung cancer: a ...
ALK Mutation Test Price, Range and Preparations | mediSuggest
Figure 1 from Acquired ALK L1152R Mutation Confers Resistance to ...
ALK F1174S mutation impairs ALK kinase activity in EML4-ALK variant 1 ...
Frontiers | ALK F1174S mutation impairs ALK kinase activity in EML4-ALK ...
A Pan-Cancer Review Of Alk Mutations Implications For Carcinogenesis ...
PPT - ALK and ALCL PowerPoint Presentation, free download - ID:3936411
Schematic summary of different categories of ALK alterations (gene ...
Germline and somatic ALK mutations.a, Schematic diagram indicating ...
Activity of Brigatinib in Patients With Crizotinib-Resistant ALK ...
ALK mutations in non-small cell lung cancer. Most mutations of the ALK ...
Prediction of ALK mutations mediating ALK-TKIs resistance and drug re ...
PPT - The Role of Alk in Anaplastic Large-cell Lymphoma (ALCL ...
Figure 1 from Sequential ALK Inhibitors Can Select for Lorlatinib ...
Signalling pathways associated with ALK. Missense mutations in ALK ...
ALK inhibitors in cancer: mechanisms of resistance and therapeutic ...
ALK Mutations Conferring Differential Resistance to Structurally ...
ALK Mutation: Purpose, Price, Procedure & Results | Drlogy
Treatment of advanced ALK+ NSCLC, 5th-generation of ALK TKI | LCTT
Genetic inhibition of ALK with specific siRNA. (A) Knockdown of ALK (or ...
Prevalence and natural history of ALK positive non-small-cell lung ...
NVL-655 Is a Selective and Brain-Penetrant Inhibitor of Diverse ALK ...
Solvent-front mutations and its compound mutants were resistant against ...
Acquired Resistance Mutations to ALK Inhibitors Identified by Single ...
ALK mutations and their impact on the efficiency of ALK inhibitors ...
Patient Characteristics of the cases with ALK Mutation. | Download ...
Two Novel ALK Mutations Mediate Acquired Resistance to the Next ...
(PDF) Lorlatinib and compound mutations in ALK+ large-cell ...
Representative ALK inhibitors (compounds 50−54) with the DAAPs scaffold ...
Identification of ALK mutations in leukemia patient samples. A ...
Molecular Mechanisms of Resistance to First- and Second-Generation ALK ...
Diverse Resistance Mechanisms to the Third-Generation ALK Inhibitor ...
ALK Kinase Domain Mutations in Primary Anaplastic Large Cell Lymphoma ...
ALK mutations in neuroblastoma patients. Frequency distribution of ...
Emerging Roles of ALK in Immunity and Insights for Immunotherapy
Activating mutations in ALK provide a therapeutic target in ...
Human ALK variants are suppressed by mutations in the identified ...
(PDF) Prediction of ALK mutations mediating ALK-TKIs resistance and ...
Relevance of Detection of Mechanisms of Resistance to ALK Inhibitors in ...
Frontiers | The Resistance Mechanisms and Treatment Strategies for ALK ...
Screenshots from integrated genome viewer illustrating the compound in ...
Lorlatinib and compound mutations in ALK+ large-cell neuroendocrine ...
ALK mutations increased phosphorylation of ALK signaling pathways and ...
(A) ALK resistance mutations in plasma samples after progression on an ...
Analysis of lorlatinib analogs reveals a roadmap for targeting diverse ...
TSR-011 (ALK INHIBITOR) NSCLC AND OTHER CANCERS TESARO, INC.
Slide Show - Understanding NSCLC Treatment for Less Common Mutations ...
Progression patterns, resistant mechanisms and subsequent therapy for ...
Dynamic monitoring of circulating tumor DNA to analyze genetic ...
Structure model of the ALK-gilteritinib complex and the predicted ...
Preclinical Prediction of Resistance Mutations and Proposal of ...
Identification of gilteritinib as an inhibitor of ALK-rearranged cancer ...
Real-world circulating tumor DNA analysis depicts resistance mechanism ...
TPX-0131, a Potent CNS-penetrant, Next-generation Inhibitor of Wild ...
Clinical utility of liquid biopsy for the diagnosis and monitoring of ...
Therapeutic Targeting of Anaplastic Lymphoma Kinase in Lung Cancer: A ...
RCSB PDB - 9GBE: Structure of Human Anaplastic Lymphoma Kinase (ALK ...
(PDF) Case report: SAF-189s is a potent inhibitor in a lorlatinib ...
Alk-rearranged lung adenocarcinoma: From molecular genetics to ...
Stephen V Liu, MD on Twitter: "Dr. @JessicaJLinMD highlights some ...
Acquired resistance mutations in patient-derived ALK+ ALCL cell lines ...
ALK-rearrangement in non-small-cell lung cancer (NSCLC). - Abstract ...
Frontiers | Case report: SAF-189s is a potent inhibitor in a lorlatinib ...
Experimental and Therapeutic Medicine
| IJGM | Dove Medical Press
ALK-1 cDNA with mutations identified in patients with HHT related ...
Ceritinib and brigatinib overcome Ba/F3 cells with I1171S + G1269A ...
